ArticleCureus2026
Patient Blood Management for a Transfusion Dilemma Associated With a Rare Blood Group: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patient blood management (PBM) is a patient-centered, evidence-based approach aimed at improving outcomes by optimizing and preserving a patient's own blood, particularly when transfusion support is limited. We report a 76-year-old female with congestive heart failure and severe mitral stenosis presenting with severe iron deficiency anemia. Transfusion was not feasible due to an alloantibody against a high-frequency antigen (HFA), later identified as anti‑Inᵇ in a rare In(b-) phenotype. The patient was managed conservatively using PBM principles, including intravenous iron therapy, minimization of blood loss, and optimization of physiological tolerance to anemia through infection control. Hemoglobin levels improved steadily, and the patient remained stable without requiring a transfusion. This case highlights the importance of transfusion services and multidisciplinary collaboration in safely managing severe anemia in patients with rare blood groups/antibodies to HFAs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.